Interview with Esa M. Davis, MD, MPH, USPSTF member and coauthor of Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content:

• Screening for Osteoporosis to Prevent Fractures
• Screening for Osteoporosis to Prevent Fractures
• Fracture Risk Assessment as a Component of Osteoporosis Screening—Easier Said Than Done
• Screening for Osteoporosis to Prevent Fractures

NIH'S policies, programs, and research funding fill gaps in knowledge about women’s health. Janine Austin Clayton, MD, of the NIH joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss key programs, policies, and scientific advances of the NIH that have informed and improved women’s health. Related Content:

• Recent Developments in Women’s Health Research at the US National Institutes of Health
• National Academies Report Calls for an NIH Institute Dedicated to Women’s Health

JAMA Deputy Editor Mary McDermott, MD, and JAMA Deputy Editor Kristin Walter, MD, MS, highlight their selections of top JAMA 2024 Clinical Reviews podcasts. Related Content:

• Dialysis for Chronic Kidney Failure (podcast)
• Diagnosis and Treatment of Community-Acquired Pneumonia (CAP) (podcast)
• Obesity Medications (podcast)
• Dialysis for Chronic Kidney Failure
• Community-Acquired Pneumonia
• Medications for Obesity

Chronic kidney disease develops among 30% to 40% of people with type 1 or type 2 diabetes during their lifetime. Author Ian H. de Boer, MD, MS, of the University of Washington Division of Nephrology, discusses the evaluation and treatment of chronic kidney disease in patients with type 1 and type 2 diabetes with JAMA Senior Editor Karen Lasser, MD, MPH. Related Content:

• Diabetes and Chronic Kidney Disease

The number of people living with atrial fibrillation (AF) is increasing, and they have a higher rate of cardiovascular events, chronic kidney disease, and dementia compared with people without AF. Emelia J. Benjamin, MD, ScM, an epidemiologist and cardiologist, discusses current diagnosis and treatment of AF with JAMA Deputy Editor Mary McGrae McDermott, MD. Related Content:

• Atrial Fibrillation

Allogeneic stem cell transplantation is a potentially life-saving therapy for some patients with hematologic and bone marrow cancers and certain nonmalignant conditions such as sickle cell disease. Hermioni L. Amonoo, MD, MPP, MPH, of Harvard Medical School and Dana-Farber Cancer Institute, joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the process of allogeneic stem cell donation. Related Content:

• Allogeneic Stem Cell Donation

JAMA Senior Editor Derek Angus, MD, MPH, and JAMA Associate Editor Christopher Seymour, MD, MSc, discuss 4 critical care trials published in JAMA and simultaneously presented at the 2024 CCR Down Under meeting in Melbourne, Australia, with JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content:

• Electronic Sepsis Screening Among Patients Admitted to Hospital Wards
• Early Restrictive vs Liberal Oxygen for Trauma Patients
• High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure
• Do Sepsis Alerts Help?
• Reevaluating Respiratory Support in Acute Respiratory Failure—Insights From the RENOVATE Trial and Implications for Practice
• Is High-Flow Oxygen the Standard for All Patients With Acute Respiratory Failure?
• Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis

Access to obstetric care in US hospitals has been declining, while maternal mortality is on the rise. A new research letter published in JAMA quantifies losses and gains of obstetric care at rural and urban short-term acute care hospitals in the US between 2010-2022. Author Katy Kozhimannil, PhD, MPA, discusses this and more with JAMA Deputy Editor Linda Brubaker, MD, MS. Related Content:

• Obstetric Care Access at Rural and Urban Hospitals in the United States

Ovarian aging is an important cause of infertility in women older than 35 years. Success rates of fertility treatment decline with age, most commonly due to declining ovarian function. Author Albert L. Hsu, MD, MS, of University of Cincinnati, Ohio, discusses this and more with JAMA Deputy Editor Kristin L. Walter, MD, MS. Related Content:

• Ovarian Aging and Fertility

Mpox is an evolving global health threat, and clinicians should be aware of characteristic signs and symptoms to ensure timely diagnosis and appropriate management. Author Jason Zucker, MD, MS, of Columbia University Irving Medical Center speaks with JAMA Deputy Editor Preeti Malani, MD, MSJ, about the transmission, diagnosis, management, and prevention of mpox. Related Content:

• Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies
• The Resurgence of Mpox in Africa
• Decline of Mpox Antibody Responses After Modified Vaccinia Ankara–Bavarian Nordic Vaccination
• WHO Announces Mpox Global Plan, Appeals for Funding